Neutralization Assay Team, Innovation Lead
- Employer
- Spark Therapeutics
- Location
- Philadelphia, Pennsylvania. Hybrid and remote options available for select opportunities.
- Salary
- Salary not provided
- Closing date
- Jun 7, 2023
View more
- Discipline
- Life Sciences, Biotechnology
- Organization Type
- Pharma
Job Details
- Bench-level work is required at least 50-60% of the time.
- Manage activities of bench-level scientist(s)
- Develop next-generation cell-based NAb assays and Ligand binding assays using ELISA and/or ECLIA methodologies and establish appropriate methods for patient screening and exclusion.
- Lead the assay transfer of total Ab and cell-based NAb assays to assay validation teams and external CRO partners including CLIA-certified labs.
- Interface with the Translational Science team’s CDx Lead to support the transfer of internal laboratory developed tests to CLIA-certified labs.
- Interface with project teams as needed to serve as the bioanalytical representative for programs in the portfolio.
- Ph.D. with 5+ or Masters with 6+years of experience.
- Degree in Immunology, Cell Biology, or other relevant areas of Biology.
- Knowledge of AAV Gene Therapy.
- Experience with cell-based assays and ELISAs/MSD is a must.
- Bioanalytical experience in regulated and/or discovery bioanalysis including ADA and NAb assays.
- Hands-on experience developing and validating reporter-based, and ligand-binding NAb assays. NAb assay development in biologics may be a transferable skill.
- Hands-on experience in immunogenicity (ADA) assays.
- Experience with CLIA-certified assays desired.
Please be aware that Spark mandates COVID-19 vaccination of all employees regardless of work location. Accommodations may be made in accordance with applicable law.
Spark Therapeutics does not accept unsolicited resumes/candidate profiles from any source other than directly from candidates. Any unsolicited resume/candidate profile submitted through our website or to personal email accounts of employees of Spark Therapeutics are considered property of Spark Therapeutics and are not subject to payment of agency fees.
Nearest Major Market: Philadelphia
Join the Spark Team
We were born of innovation, springing from the curiosity, imagination and dedication of remarkable scientists and healthcare visionaries. Our shared mission is to challenge the inevitability of genetic disease by discovering, developing, and delivering treatments in ways unimaginable - until now.
We don't follow footsteps. We create the path.
Learn more about Spark Therapeutics and view other openings.
Company
At Spark Therapeutics, a fully integrated, commercial company committed to discovering, developing and delivering gene therapies, we challenge the inevitability of genetic diseases, including blindness, hemophilia, lysosomal storage disorders and neurodegenerative diseases.
Founded in March 2013 as a result of the technology and know-how accumulated over two decades at Children’s Hospital of Philadelphia (CHOP), our investigational therapies have the potential to provide long-lasting effects, dramatically and positively changing the lives of patients with conditions where no, or only palliative, therapies exist. Greater understanding of the human genome and genetic abnormalities have allowed our scientists to tailor investigational therapies to patients suffering from very specific genetic diseases. This approach holds great promise in developing effective treatments to a host of inherited diseases. Our initial focus is on treating orphan diseases.
Headquartered in dynamic Philadelphia, we are a diverse, experienced team united in our goal to break down barriers for people and families affected by genetic diseases. As our name suggests, our investigational, one-time therapies are designed to spark healthy biology, and deliver potentially life-altering transformation for people and families affected by genetic disease. Spark is a member of the Roche Group.
- Website
- http://sparktx.com/
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert